Heparin-induced thrombocytopenia.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  International Anesthesiology Clinics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00004311-200404230-00005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The frequency of thrombocytopenia in patients with heart disease treated with oral diuretics.

  2009cited by this paper
• Heparin-associated thrombocytopenia: Successful therapy with the heparinoid Org 10172 in a patient showing cross-reaction to LMW heparins

  2005cited by this paper
• Anti‐PF4–heparin immunoglobulin G is the major class of heparin‐induced thrombocytopenia antibody: findings of an enzyme‐linked immunofiltration assay using membrane‐bound hPF4–heparin

  2001cited by this paper
• Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia

  2001influential reference
• Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation.

  2000cited by this paper
• A COMPARISON OF RECOMBINANT HIRUDIN WITH A LOW-MOLECULAR-WEIGHT HEPARIN TO PREVENT THROMBOEMBOLIC COMPLICATIONS AFTER TOTAL HIP REPLACEMENT

  2000cited by this paper
• Intraoperative monitoring of danaparoid sodium anticoagulation during cardiovascular operations.

  1998cited by this paper
• Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant hirudin.

  1998cited by this paper
• Heparin-induced Thrombocytopenia: Towards Consensus

  1998influential reference
• Heparin-induced skin lesions.

  1998cited by this paper
• Orgaran (Org 10172) for cardiopulmonary bypass in heparin-induced thrombocytopenia: role of adjunctive plasmapheresis.

  1997cited by this paper
• Monitoring of r-Hirudin Anticoagulation during Cardiopulmonary Bypass – Assessment of the Whole Blood Ecarin Clotting Time

  1997cited by this paper
• Heparin‐induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution

  1997influential reference
• Organization to Assess Strategies for Ischemic Syndromes (OASIS).

  1997cited by this paper
• Recombinant Hirudin in the Prevention of Venous Thromboembolism in Patients Undergoing Elective Hip Surgery

  1997cited by this paper
• Anticoagulation with Novastan® (Argatroban) in Patients with Heparin-Induced Thrombocytopenia and Heparin-Induced Thrombocytopenia and Thrombosis Syndrome

  1997cited by this paper
• Heparin‐induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular diseases

  1997cited by this paper
• Direct Thrombin Inhibitors: Appraisal of the Antithrombotic/ Hemorrhagic Balance

  1997cited by this paper
• Prevention of Thromboembolism with Use of Recombinant Hirudin. Results of a Double-Blind, Multicenter Trial Comparing the Efficacy of Desirudin (Revasc) with That of Unfractionated Heparin in Patients Having a Total Hip Replacement*

  1997cited by this paper
• Subcutaneous Recombinant Hirudin (HBW 023) Versus Intravenous Sodium Heparin in Treatment of Established Acute Deep Vein Thrombosis of the Legs: a Multicentre Prospective Dose-ranging Randomized Trial

  1997cited by this paper
• Heparin-related thrombosis despite normal platelet counts in vascular surgery.

  1997cited by this paper
• Pharmacokinetics of Recombinant Hirudin in Hemodialyzed End-stage Renal Failure Patients

  1997cited by this paper
• Hirudins: From Leeches to Man

  1996cited by this paper
• Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393.

  1996cited by this paper
• Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172.

  1996cited by this paper
• Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial.

  1996cited by this paper
• A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes.

  1996cited by this paper
• Cross-reactivity study of low molecular weight heparins and heparinoid in heparin-induced thrombocytopenia.

  1996cited by this paper
• Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia.

  1996cited by this paper
• A 14-year study of heparin-induced thrombocytopenia.

  1996influential reference
• Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

  1995influential reference
• Successful treatment of heparin-associated thrombocytopenia and thrombosis using Hirulog.

  1995cited by this paper
• Heparin associated thrombocytopenia.

  1995cited by this paper
• Antigen Generation in Heparin-Associated Thrombocytopenia: The Nonimmunologic Type and the Immunologic Type Are Closely Linked in Their Pathogenesis

  1995influential reference
• Heparin-induced thrombocytopenia

  1995cited by this paper
• Heparin-induced thrombocytopenia and thrombosis.

  1995cited by this paper
• Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia.

  1995cited by this paper
• Do patients with the heparin-induced thrombocytopenia syndrome have heparin-specific antibodies?

  1995cited by this paper
• Comparing Subcutaneous Danaparoid with Intravenous Unfractionated Heparin for the Treatment of Venous Thromboembolism

  1995cited by this paper
• Recombinant hirudin as a new anticoagulant during cardiac operations instead of heparin: successful for aortic valve replacement in man.

  1995cited by this paper
• Use of recombinant hirudin as antithrombotic treatment in patients with heparin‐induced thrombocytopenia

  1995cited by this paper
• Antibodies to Macromolecular Platelet Factor 4-Heparin Complexes in Heparin-induced Thrombocytopenia: a Study of 44 Cases

  1995cited by this paper
• Transient global amnesia associated with acute heparin-induced thrombocytopenia.

  1994cited by this paper
• Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes [see comments]

  1994cited by this paper
• Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4.

  1994cited by this paper
• Alteration of platelet function in dogs mediated by interleukin-6.

  1994cited by this paper
• Low-molecular-weight heparins in prophylaxis and therapy of thromboembolic diseases

  1994cited by this paper
• Laboratory diagnosis of heparin‐associated thrombocytopenia and comparison of platelet aggregation test, heparin‐induced platelet activation test, and platelet factor 4/heparin enzyme‐linked immunosorbent assay

  1994cited by this paper
• Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.

  1994cited by this paper
• Can heparin cause adult respiratory distress syndrome by a similar mechanism as heparin-associated thrombocytopenia?

  1994cited by this paper
• Management of cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia using prostaglandin E1 and aspirin.

  1994cited by this paper
• Crossreactivity Studies between Sera of Patients with Heparin Associated Thrombocytopenia and a New Low Molecular Weight Heparin, Reviparin

  1994cited by this paper
• Treatment of Severe Venous Thrombo-Embolism with Intravenous Hirudin (HBW 023): An Open Pilot Study

  1993cited by this paper
• Heparin-associated thrombocytopenia: a critical review and pooled analysis.

  1993cited by this paper
• Perioperative paraplegia and multiorgan failure from heparin-induced thrombocytopenia.

  1993cited by this paper
• Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass.

  1993cited by this paper
• Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?

  1993cited by this paper
• Heparin-Induced Thrombocytopenia (HIT): An Overview of 230 Patients Treated with Orgaran (Org 10172)

  1993influential reference
• The Clinical Usefulness of the Platelet Aggregation Test for the Diagnosis of Heparin-Induced Thrombocytopenia

  1993cited by this paper
• Heparin‐induced thrombocytopenia and thrombosis: clinical and laboratory studies

  1993cited by this paper
• Platelet aggregation studies for the diagnosis of heparin-induced thrombocytopenia.

  1993cited by this paper
• Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis: Hull RD, Raskob GE, Pineo GF, et al. N Engl J Med 1992;326:975-82

  1993cited by this paper
• Heparin-associated thrombocytopenia type II in a patient with end-stage renal disease: successful anticoagulation with the low-molecular-weight heparinoid Org 10172 during haemodialysis.

  1993cited by this paper
• Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia.

  1992cited by this paper
• Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group.

  1992cited by this paper
• Platelet Factor 4 Complexed to Heparin Is the Target for Antibodies Generated in Heparin-Induced Thrombocytopenia

  1992cited by this paper
• Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.

  1992cited by this paper
• Letter to the editor: Heparin‐induced thrombocytopenia‐response to intravenous immunoglobulin in vivo and in vitro

  1992cited by this paper
• Thrombocytopoiesis in normal and sublethally irradiated dogs: response to human interleukin-6

  1992cited by this paper
• Successful Use of the APTT in Monitoring of the Anti-Factor Xa Activity of the Heparinoid Organon 10172 in a Case of HITS Requiring Open Heart Surgery

  1992cited by this paper
• A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke

  1992cited by this paper
• Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

  1992cited by this paper
• Response of human platelets to activating monoclonal antibodies: importance of Fc gamma RII (CD32) phenotype and level of expression.

  1992cited by this paper
• Parenteral Anticoagulation with the Heparinoid Lomoparan (Org 10172) in Patients with Heparin Induced Thrombocytopenia and Thrombosis

  1992influential reference
• Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia.

  1991cited by this paper
• Heparin‐induced thrombocytopenia and thrombosis: Reversal with streptokinase a case report and review of literature

  1991cited by this paper
• Thrombocytopenia associated with low-molecular-weight heparin

  1991cited by this paper
• Plasmapheresis. A therapeutic option in the management of heparin-associated thrombocytopenia with thrombosis.

  1991cited by this paper
• A Rapid and Sensitive Test for Diagnosing Heparin-Associated Thrombocytopenia

  1991cited by this paper
• The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis.

  1991cited by this paper
• Combined Administration of Aspirin and a Specific Thrombin Inhibitor in Man

  1991cited by this paper
• Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.

  1990cited by this paper
• Large-dose infusions of heparinoid ORG 10172 in ischemic stroke.

  1990cited by this paper
• Plasma exchange and heparin-induced thrombocytopenia.

  1990cited by this paper
• Heparin-associated skin necrosis.

  1990cited by this paper
• "Heparin-free" cardiopulmonary bypass: first reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass.

  1990cited by this paper
• Intraoperative management of patients with heparin-induced thrombocytopenia.

  1990cited by this paper
• Heparinoid ORG 10172 anticoagulation for cardiopulmonary bypass: A case report

  1990cited by this paper
• Characterization of the Fcγ receptor on human platelets

  1990cited by this paper
• Thrombocytopenia associated with heparin-coated catheters in patients with heparin-associated antiplatelet antibodies.

  1989cited by this paper
• Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis.

  1989cited by this paper
• Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172

  1989cited by this paper
• Surgical management of heparin-associated thrombocytopenia. Strategies in the treatment of venous and arterial thromboembolism.

  1988cited by this paper
• Plasmapheresis in the management of heparin‐associated thrombocytopenia with thrombosis

  1988cited by this paper
• White clot syndrome.

  1988cited by this paper
• Heparin-induced thrombocytopenia: laboratory studies.

  1988cited by this paper
• Treatment of serious heparin-induced thrombocytopenia by plasma exchange: report on 4 cases.

  1988cited by this paper
• Heparin-associated thrombocytopenia and thrombosis.

  1988cited by this paper
• Heparin-coated catheters and heparin-induced thrombocytopenia.

  1988cited by this paper
• Immune endothelial-cell injury in heparin-associated thrombocytopenia.

  1987cited by this paper

• Rats subject to extracorporeal membrane oxygenation have improved cardiac function following anticoagulation and reversal with factor IXa aptamer-antidote oligonucleotide pair

  2025cites this paper
• Heparin Resistance and Intracardiac Thrombosis May Be a Harbinger of Heparin-Induced Thrombocytopenia (HIT).

  2018cites this paper
• Anticoagulation Therapy during Extracorporeal Membrane Oxygenator Support in Pediatric Patients

  2017cites this paper
• Massive Pulmonary Embolism in a Patient with Heparin Induced Thrombocytopenia: Successful Treatment with Dabigatran.

  2016cites this paper
• Pharmacotherapy of heparin-induced thrombocytopenia: therapeutic options and challenges in the clinical practices.

  2015cites this paper
• Current view of coagulation system

  2014cites this paper
• Have You Been HIT?

  2011cites this paper
• TREATMENT FOR HEPARIN-INDUCED THROMBOCYTOPENIA Review Article

  2011cites this paper
• Heparin-induced thrombocytopaenia/thrombosis: a clinicopathologic review.

  2010cites this paper
• Bleeding and Hemostasis

  2010cites this paper
• Heparin and Oversulfated Heparin Byproduct Induce Thrombin Generation Through Contact System Activation in Plasma of Patients With HIT

  2010cites this paper
• Agents for the treatment of heparin-induced thrombocytopenia.

  2010cites this paper
• Molecular mechanism underlines heparin-induced thrombocytopenia and thrombosis.

  2010cites this paper
• Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.

  2009cites this paper
• Effects of cardiac surgery on hemostasis.

  2006cites this paper
• Update on anticoagulant medications for the interventional radiologist.

  2006cites this paper
• Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children.

  2006cites this paper
• Heparin Induced Thrombocytopenia - Thrombosis Due to Low Molecular Weight Heparin in Orthopedic Patients

  2006cites this paper
• Transitioning from Argatroban to Warfarin Therapy in Patients with Heparin-induced Thrombocytopenia

  2005cites this paper
• Bivalent direct thrombin inhibitors: hirudin and bivalirudin.

  2004cites this paper
• Severe argatroban-induced coagulopathy in a patient with a history of heparin-induced thrombocytopenia.

  2004cites this paper
• Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.

  2003cites this paper
• Excessive Argatroban Anticoagulation for Heparin-Induced Thrombocytopenia

  2003cites this paper